Pasireotide is a long-acting cyclic hexapeptide somatostatin analog that effectively reduces the secretion of GH (growth hormone), IGF-I (insulin-like growth factor-I) and ACTH (adrenocorticotropic hormone) by inhibiting the action of somatostatin receptors.